Target of Rapamycin (TOR) is a major nutrition and energy sensor that regulates growth and life span in yeast and animals. In plants, growth and life span are intertwined not only with nutrient acquisition from the soil and nutrition generation via photosynthesis but also with their unique modes of development and differentiation. How TOR functions in these processes has not yet been determined. To gain further insights, rapamycin-sensitive transgenic Arabidopsis thaliana lines (BP12) expressing yeast FK506 Binding Protein12 were developed. Inhibition of TOR in BP12 plants by rapamycin resulted in slower overall root, leaf, and shoot growth and development leading to poor nutrient uptake and light energy utilization. Experimental limitation of nutrient availability and light energy supply in wild-type Arabidopsis produced phenotypes observed with TOR knockdown plants, indicating a link between TOR signaling and nutrition/light energy status. Genetic and physiological studies together with RNA sequencing and metabolite analysis of TOR-suppressed lines revealed that TOR regulates development and life span in Arabidopsis by restructuring cell growth, carbon and nitrogen metabolism, gene expression, and rRNA and protein synthesis. Gain-and loss-of-function Ribosomal Protein S6 (RPS6) mutants additionally show that TOR function involves RPS6-mediated nutrition and light-dependent growth and life span in Arabidopsis.
INTRODUCTION
Among all extant organisms, many of the longest living species are plants. For example, a creosote bush (Larrea tridentata) called King Clone, which has lived for over 10,000 years, was found in the Mojave Desert (Vasek, 1980) . The giant redwood trees in California (Sequoia sempervirens) live for well over 2000 years (Scheres, 2007) and several other tree species have a long life span. However, the mechanisms that underpin longevity in plants are not known. Dissecting the control mechanisms of growth and life span in plants has many implications. It will provide a framework for addressing the key components and regulators of life span in plants. Engineering life span in plants has multiple applications, including early maturation for short seasons, long-lasting horticultural plants, and trees of desirable life span in silviculture (McCouch, 2004; Neale, 2007; Takeda and Matsuoka, 2008; Sonah et al., 2011) . Recent work identified genetic factors that can be modified via breeding techniques to improve crop yield through modulating the growth phases (Moose and Mumm, 2008) . Uauy et al. (2006) showed that a NAC transcription factor-mediated acceleration of senescence impacted nutrient remobilization in wheat (Triticum aestivum), resulting in significant increase in protein content and micronutrients in the grains (Uauy et al., 2006) . Thus, life span alteration can have several beneficial outcomes.
Plants are distinct from most other multicellular eukaryotes in having a modular body plan with immortal totipotent stem cells, sessile but autotrophic lifestyle, and very extensive biosynthetic capabilities and adaptation to various stress factors. Therefore, the determinants of growth habit and life span are expected to be different in plants and animals (Thomas, 2002) . Nevertheless, it is important to determine if plants and animals share any common regulators or mediators of the processes involved. In this regard, the Target of Rapamycin (TOR) pathway is a fundamental commonality. In other eukaryotes, the TOR signaling pathway is considered to have a central role in sensing nutrient and energy status. It plays a critical role in regulating cellular metabolism (Fontana et al., 2010; Laplante and Sabatini, 2012) and anabolic functions through alterations in ribosome biogenesis, mRNA translation, and polysome integrity (Proud, 2004; Tavernarakis, 2008) . The essential role of TOR in plants became evident as research showed that mutations in TOR caused embryo lethality (Menand et al., 2002) . Although the roles of TOR in postembryonic plant growth and life span are largely undetermined, experimental findings suggest TOR involvement in the regulatory program that coordinates cell wall components with cell elongation as well as growth and development in plants (Leiber et al., 2010) . Plant cell growth is tightly linked to the physico-chemical aspects of the cell wall. The components and processes associated with cell wall extension are critical for cell enlargement and organ growth (Carpita and Gibeaut, 1993; Martin et al., 2001) . Mutation in Lethal with Sec Thirteen8 (LST8), a member of the TOR complex, leads to cell wall alteration and reduction of vegetative growth in Arabidopsis thaliana (Moreau et al., 2012) . TAP46, another factor that functions as a positive downstream effector of TOR, regulates the growth and metabolism of plants via modulation of polysome abundance and global translation activities in response to the nutrient availability (Ahn et al., 2011) .
Ribosome biogenesis and protein synthesis command a major portion of available nutrients and energy in growing cells of all eukaryotic species and affect the growth rate and life span (Byrne, 2009; Lempiäinen and Shore, 2009 ). The TOR signaling pathway tightly couples energy and nutrient availability to protein and ribosome production (Wullschleger et al., 2006) . Inhibition of the TOR signaling pathway by nutrient starvation, rapamycin treatment, or genetic mutation results in rapid downregulation of protein synthesis and ribosome biogenesis in diverse eukaryotes (Li et al., 2006) . Mechanistically, TOR acts as a protein kinase to change the phosphorylation state of many target proteins. Ribosomal protein S6 (RPS6) is a key component of the 40S ribosomal subunit, integrating t-RNA recruitment to mRNA and translation initiation factors, and thus regulating translation of mRNAs (Ruvinsky and Meyuhas, 2006) . In mammals, RPS6 was the first identified ribosomal protein target of inducible phosphorylation by growth factors and also by ribosome protein S6 protein kinase (S6K) (Krieg et al., 1988; Franco and Rosenfeld, 1990; Ruvinsky and Meyuhas, 2006) . S6K is a known target of mammalian TOR, participating in the TOR signaling pathway to regulate growth and life span in mice (Pende et al., 2004; Holz et al., 2005; Selman et al., 2009) . Additionally, in yeast, RPS6 regulates cell size, growth, and life span (Fabrizio et al., 2001; Chiocchetti et al., 2007) , suggesting a coordination with TOR.
In Arabidopsis, a connection of the TOR signaling pathway to growth was apparent when embryo lethality was observed in TOR T-DNA insertion mutants (Menand et al., 2002; Ren et al., 2011) . Also, mutants lacking TOR pathway components, including S6K, LST8, TAP46, and RPS6, were lethal at an early stage (Creff et al., 2010; Henriques et al., 2010; Ahn et al., 2011; Moreau et al., 2012) . Rapamycin, an immunosuppressant drug that was first discovered as an antifungal compound, is a valuable tool for dissecting the functions of the TOR pathway in mammalian and other systems (e.g., yeast) (Loewith and Hall, 2011) . Rapamycin specifically binds to FKBP12 (for FK506 binding protein 12), which interacts with the FRB domain of TOR, and the resultant rapamycin-FKBP12-TOR inhibitory complex renders the TOR pathway inactive (Heitman et al., 1991; Stan et al., 1994; Zheng et al., 1995; Loewith et al., 2002) . Studies with Arabidopsis have shown that rapamycin treatment does not produce phenotypes associated with inhibition of TOR, and this is attributed to structural differences of the target Arabidopsis FKBP12 proteins, which are unlike their yeast or mammalian counterparts (Xu et al., 1998; Menand et al., 2002; Sormani et al., 2007) . This is further supported by studies that showed that transgenic Arabidopsis plants that expressed yeast or human FKBP12 proteins are rapamycin sensitive Leiber et al., 2010; Xiong and Sheen, 2012) .
This study was designed to gain further insights into the postembryonic plant growth and life span roles of the TOR signaling pathway and its downstream effectors in plants through analysis of yeast FKBP12-based rapamycin-sensitive Arabidopsis transgenic lines (BP12) as well as in conjunction with rsp6 mutants. Independent BP12 lines as well as the rps6 mutants produced phenotypes of reduced root and leaf growth but an extended life span. Furthermore, we report that these phenotypes were associated with increased catabolism, as evident from metabolite and transcript profiles. These studies demonstrate that TOR signaling in concert with RPS6 as a downstream component couples metabolic processes associated with growth and life span to nutritional and light energy status in Arabidopsis.
RESULTS

Establishment of Rapamycin-Sensitive Arabidopsis Lines Expressing Yeast FKBP12
We generated 81 independent transgenic Arabidopsis lines (BP12 lines) by expressing the yeast FKBP12 gene under the control of a constitutive (cauliflower mosaic virus 35S) promoter. None of these lines showed any detectable or visible developmental or growth defects. PCR identification of 29 T1 lines confirmed the presence of FKBP12 in all the lines except line 24 ( Figure 1A ). From these 28 T1 independent lines, 12 T2 BP12 lines (lines 1 to 12) were selected for rapamycin sensitivity and segregation analysis in the T2 generation. Compared with wild-type plants, all 12 independent BP12 lines were responsive to rapamycin treatment, causing phenotypes including slower plant growth with shorter shoots and roots (see Supplemental Figure 1A online). Copy number for FKBP12 in these 12 lines was verified by DNA gel blots: The BP12-2 line contained a single copy, BP12-1 two copies, BP12-4 and BP12-6 three copies each, and the rest of the transformed lines had multiple copies ( Figure 1B ). We selected five independent T3 generation lines, BP12-1 to BP12-5, and confirmed the expression of the FKBP12 transcript and corresponding protein in all of them ( Figure 1C ). Then, seedling growth of BP12-1, BP12-2, BP12-4, and BP12-5 lines was examined in the same plate at incremental rapamycin concentrations, 0.5 to 20 µg/mL in the medium, using 0.53 Murashige and Skoog (MS) containing 1 µg/mL DMSO as controls ( Figure 1D ). On 0.53 MS + DMSO medium, the seedling growth of these four BP12 lines was similar to wild-type plants (A) The presence of yeast FKBP12 gene was confirmed by PCR in 28 of the 29 P35S:FKBP12-Myc transgenic lines (BP12), except line 24, using 35SF1 and FKBP12R primers. M, DNA ladder; WT, the wild type. (B) DNA gel blot analysis of BP12 lines (lanes 2 to 11) showed that BP12-2 (lane 2) contained a single copy of yeast FKBP12 transgene and in the others two or more copies. (C) Expression of FKBP12 in BP12 lines 1 to 5 confirmed by RT-PCR analysis (top panel); Actin 2 was used as internal control (middle panel) (1). Immunoblot analysis using Myc epitope tag-based antibody showed the expression of yeast FKBP12 protein (bottom panel) (2). (D) Rapamycin (RAP) sensitivity of wild-type and four BP12 seedlings grown on 0.53 MS plates containing incremental concentrations of rapamycin (0.5 to 20 µg/mL) at 7 DAG. The growth of wild-type seedlings in all the rapamycin-containing medium is similar to the control without rapamycin, whereas the four BP12-2, BP12-5, BP12-1, and BP12-4 lines showed reduced root and shoot growth in the presence of rapamycin. (E) and (F) BP12-2 and BP12-5 seedlings at 7 DAG with rapamycin (10 µg/mL) showed reduced seedling length (E) and fresh weight (F) compared with the wild type. (G) Both BP12 lines displayed reduced growth rate compared with the wild type as measured by fresh weight at 7, 15, 25, 35, and 45 DAG. Error bars indicate SD for triplicates. grown on 0.53 MS medium (see Supplemental Figure 1B online), confirming that overexpression of FKBP12 does not alter plant growth or development. The growth of wild-type seedlings was no different at 0 or 20 µg/mL rapamycin but clear phenotypes affecting primary root growth, lateral root initiation, cotyledon growth, rosette leaf initiation and expansion, and shoot growth were observed in the four independent transgenic BP12 lines ( Figure 1D ). The severity of these phenotypes increased with increasing concentrations of rapamycin, with even a dose of 0.5 µg/mL rapamycin being sufficient to observe effects on seedling growth in all the four BP12 lines ( Figure 1D ). These results clearly indicate that Arabidopsis seedling growth and the observed root and shoot phenotypes are dependent on both the FKBP12 transgene expression and rapamycin, consistent with previous observations (Mahfouz et al., 2006; Sormani et al., 2007; Leiber et al., 2010) . We would like to note here that compared with the findings with transgenic Arabidopsis lines, the wild-type seedling growth was normal even at the highest concentration of rapamycin tested (i.e., 20 µg/mL medium) ( Figure 1D ). We used rapamycin at 10 µg/mL concentration in the remainder of the experiments because this level allowed BP12 lines to complete their life cycle in spite of its effect on growth, and the effects of TOR signaling at different stages of postembryonic development could be assessed.
To address subcellular localization of FKBP12, we generated 81 P35S:FKBP12-GFP (for green fluorescent protein) transgenic Arabidopsis lines, out of which 17 selected T1 lines were analyzed by PCR to confirm the presence of the transgene with GFP fusion. All the selected lines except line 13 were positive (see Supplemental Figure 1C online). We also confirmed rapamycin sensitivity in lines 1 to 9 (see Supplemental Figure 1D online), suggesting that C-terminal fusion of GFP did not significantly affect the rapamycin sensitivity of ScFKBP12 in the TOR complex. The FKBP12 protein was localized to two compartments, the nucleus and the cytoplasm (see Supplemental Figures 1E to 1G online), which is similar to the subcellular localization pattern previously observed in TOR-GFP lines (Ren et al., 2011) . The colocalization of FKBP12 with TOR protein in the nucleus and cytoplasm may be an indication of a functional interaction between these proteins in the presence of rapamycin, similar to that shown in yeast and animal systems (Li et al., 2006; Wullschleger et al., 2006) .
Rapamycin Affects TOR Kinase in BP12-2
TOR kinase function involves phosphorylation of its downstream target proteins, such as S6K, 4E-BP1, AKT, and TAP46. Phosphorylation of S6K at Thr-389 residue (pT389) has been used to monitor TOR activity in mammals (Wullschleger et al., 2006) . Since the human S6K (Hs-S6K) and Arabidopsis S6K (At-S6K) homologs share a similar consensus phosphorylation motif for TOR (Turck et al., 1998) , it is possible to detect the phosphorylation status of human S6K (Hs-S6K) as substrate for Arabidopsis TOR kinase using an Hs-S6K (p70-S6K-pT389) specific antibody. Therefore, we explored this possibility in BP12 lines with the Hs-S6K antibody by creating double transgenics expressing both FKBP12 and Hs-S6K transgenes. We introduced the human p70-S6K construct P35S:Hs-S6K (with kanamycin selection marker) in the single-copy FKBP12 homozygous BP12-2 line (with basta selection marker). T0 generation seeds were screened on 0.53 MS medium containing both Basta and kanamycin. Nine independent lines containing both P35S:Hs-S6K and P35S:FKBP12 were identified by PCR and RT-PCR (see Supplemental Figures 2A and 2B online) . The S6K/BP12-2 line that showed the highest expression level of HsS6K was used to determine At-TOR kinase activity. The ELISA data showed that, in S6K/BP12-C plants, 76.01% of S6K proteins were phosphorylated at Thr-389 by TOR kinase protein in the control, whereas in the presence of rapamycin, S6K protein phosphorylation was reduced to 24.05%, indicating that rapamycin significantly inhibited TOR kinase activity (see Supplemental Figure  2C online). A recent study also used Hs-S6K (p70-S6K-pT389) specific antibody to monitor TOR activity in Arabidopsis (Xiong and Sheen, 2012) .
Inhibition of TOR Signaling Suppresses Plant Growth and Development
TOR has been shown to promote anabolic activity and cell growth in yeast and animals (Topisirovic and Sonenberg, 2010) . To explore the possible links between TOR and plant growth, we selected BP12-2, with a single FKBP12 transgene copy, and BP12-5, with multiple copies, for further study. In the presence of rapamycin, both BP12-2 and BP12-5 displayed a consistent reduction in growth and uniform rapamycin-sensitive phenotypes. The wild type did not have any discernible phenotypes. The transgenic lines showed a significant reduction in seedling length ( Figure 1E ) and fresh weight ( Figure 1F ) compared with the wild type at 7 d after germination (DAG). The slow growth was more pronounced (12-fold) by 45 DAG ( Figure 1G ). Also, the growth of primary and lateral roots was significantly inhibited in BP12-2 and BP12-5 plants ( Figure 2A ). Closer examination of the roots showed that the root hair growth was severely inhibited by rapamycin in BP12-2 and BP12-5 lines compared with the wild type ( Figures 2B and 2E ). Since the root apical meristem (RAM) size is defined by the proliferation of the transit amplifying cells (TACs), the daughter cells of the stem cells (Scheres, 2007) , we compared the RAM region of BP12-2 and the wild type. BP12-2 RAM showed a significant reduction in the TAC zone resulting in a smaller RAM (Figures 2E and 2F) . This is likely due to decreased cell division rate in the meristem region and in the TAC zone. The smaller RAM in BP12-2 was associated with differentiation of the xylem tracheary elements closer to the RAM region compared with the wild type (Figures 2F and 2G) .
To investigate the effects of rapamycin treatment on cell elongation, we focused on the hypocotyl region of seedlings, which shows rapid cell elongation in the dark. Upon rapamycin treatment, both BP12-2 and BP12-5 hypocotyls elongated to only half the length of wild-type hypocotyls ( Figure 2C ). Elongation of cells from the mid-region of the hypocotyl was reduced by 50% in BP12-2 and BP12-5 compared with the wild type ( Figure 2D ). We also examined cell size in epidermal, palisade, and spongy mesophyll cells of the leaves treated with rapamycin. Significantly smaller cells (3 6 0.2-fold, n = 50) were observed in rapamycin-treated BP12-2 line (Figures 2H to 2K) but not the wild type. Together, these results indicate that TOR activity is required for normal cell elongation and expansion in Arabidopsis.
Suppression of TOR Activity Influences Metabolism in Arabidopsis
Changes in cellular metabolism, particularly the accumulation of amino acids in response to suppression of TOR signaling, have been previously observed in yeast, animals, and Arabidopsis (Chen and Kaiser, 2003; Laplante and Sabatini, 2012; Moreau et al., 2012) . To ascertain which metabolic changes accompany the growth pattern of TOR suppression lines, we analyzed metabolite profiles in the BP12-2 and BP12-5 lines and in the wild type in the presence or absence of rapamycin. Both the transgenic lines showed robust rapamycin-dependent responses, but the wild type exhibited few changes (Figures 3A and 3B ; see Supplemental Figure 3 online). Quite remarkably, rapamycin significantly affected primary metabolism, with increases in the glycolytic and tricarboxylic acid (TCA) cycle intermediates and a large number of amino acids (Figures 3B and 3C, I and II; see Supplemental Figures 3A and 3B online) ; there were also notable (A) Principal component analysis of the metabolite data illustrating the clear separation of rapamycin-treated BP12 lines from the untreated BP12 and treated and untreated wild type (WT) based on the principal component 1 (x axis). In this analysis, the rapamycin treated wild-type line behaved similar to its untreated group, while both BP12 lines showed a strong rapamycin-dependent response. (C) Rapamycin-treated BP12 lines showed increase in carbohydrates (I) and amino acids (II) as well as decrease in peptides (III) compared with control. 1,3-DHA, 1,3-dihydroxyacetone; F-6-P, Fru-6-phosphate; G-6-P, Glc-6-phosphate; NO, no rapamycin treatment; RAP, rapamycin treatment. Error bars indicate SD for four biological replicates. The relative value of each metabolite shown is the ratio between rapamycin-treated wild type, BP12-2 and BP12-5, and nontreated wild type, BP12-2, and BP12-5 seedlings. All values indicated are statistically significant (P < 0.05) compared with the control.
increases in some components of the secondary metabolism, such as the polyamine pathway, antioxidative pathway, and phenylpropanoid pathway, in the two BP12 lines analyzed ( Figure 3B ; see Supplemental Figures 3D and 3E online) . There was an increase in methanol-extractable D-galacturonate (see Supplemental Figure 3A online). As noted above, TOR inhibition results in a reduction of hypocotyl elongation and smaller cells in the leaves (Figures 2C and 2H ). As cell expansion and tissue growth require incorporation of D-galacturonate into polymeric form in cell wall pectin, we attribute the increase in D-galacturonate to tempered cell wall assembly upon TOR inhibition. 3-Deoxyoctulosonate, another substrate for pectin synthesis, had also increased (see Supplemental Figure 3A online). Interestingly, there was a reduction in the myo-inositol level (see Supplemental Figure 3A online). Myo-inositol is a precursor of D-glucuronate that in turn can be metabolized to D-galacturonate (Reiter and Vanzin, 2001) . The TCA cycle intermediates, citrate, fumarate, malate, and succinate registered significant increases. Since photosynthesis is diminished in TOR-inhibited lines (noted below), the TCA intermediates required for cellular respiration and maintenance of growth likely arise from reorganized metabolism. Since the nitrogen supply in the growth medium was the same, regardless of rapamycin inclusion, reduced carbon fixation would be expected to distort carbon-nitrogen balance in the cells. The interrelationship in carbon-nitrogen metabolism is complex (Nunes-Nesi et al., 2010) .
Like the increase in organic acids, prominent increases in the amino acids and polyamines (Kausch et al., 2012) were apparent in rapamycin-treated BP-12 transgenic lines (Figures 3B and 3C, II; see Supplemental Figure 3B online) . The increased level of several amino acids is attributed to protein degradation as a source for energy metabolism. The reduction in dipeptides is presumably an adaptive measure of TOR-inhibited cells to make amino acids to support respiration and limited growth (Figures 3B and 3C, III; see Supplemental Figure 3C online). The decrease in Arg levels parallels a decrease in N-acetylglutamate, N-acetylornithine, Orn, and citrulline, the precursors of Arg biosynthesis (see Supplemental Figure 3B online). This decrease in Arg levels and a concomitant increase in dimethylarginine under rapamycin treatment is an indication of methylation of proteinaceous Arg. Arg dimethylation acts as an antiaging modification in Caenorhabditis elegans and increased its life span (Takahashi et al., 2011) . Decreased levels of the polyamine precursors, Arg and Orn, were noted alongside increased levels of the biogenic amines, agmatine and putrescine, and the product of their catabolism, 5-methylthioadenosine (see Supplemental Figure 3D online). These results suggest that a perceived signal generated by TOR suppression redirects carbon flow and metabolic shift to other pathways to support the growth of rapamycintreated BP12 plants.
Other metabolic alterations arising from rapamycin treatment included some secondary metabolites. The phenylpropanoid pathway generates among precursors for other products substrates for flavonoids that exist in relatively simple forms and more complex forms that are recalcitrant to methanol extraction. This pathway generates hydroxycinnamic acid (HCA)-derived monolignols that when polymerized appropriately become the lignin component of the cell wall (Vogt, 2010) . Rapamycin suppression of TOR activity led to increases in methanolextractable HCA (ferulate and sinapate) and monolignols (coniferyl alcohol) (see Supplemental Figure 3E online), supporting the inference noted above with reference to tempered cell wall assembly. Tyramine, derived from L-Tyr, can condense with hydroxycinnamoyl CoA esters to form amides that can then be incorporated in cell walls (Facchini et al., 2002) . The levels of tyramine were also lower when TOR was inhibited even though the HCA content was elevated (see Supplemental Figure 3E online).
Also, members of anti-reactive oxygen species (ROS), including 5-oxoproline, and both oxidized and reduced forms of glutathione, all increased in rapamycin-treated BP12 plants (see Supplemental Figure 3B online). The ratio of GSH/GSSG is significantly reduced in BP12 lines (GSH/GSSG = 0.73, P < 0.05) compared with the wild-type control (GSH/GSSG = 1.32, P < 0.05) indicative of active ROS quenching. In C. elegans, genetic or rapamycin inhibition of TOR activates a stress-protective response that includes glutathione S-transferase and genes involved in glutathione among others. This, while reducing growth rate, enhances life span of the worm (Robida-Stubbs et al., 2012) similar to that observed in BP12 plants treated with rapamycin. Purine and pyrimidine metabolism and also the lipid metabolism were notably the least affected by rapamycinmediated TOR signaling suppression (see Supplemental Figure  3F online). An active protein metabolism is apparent from an increase in dimethylarginine, which is posttranslationally formed in proteins (see Supplemental Figure 3B online). These changes in metabolic profiles of rapamycin-treated BP12 plants compared with the wild type indicate redirection of specific carbon and nitrogen metabolites involving both primary and secondary metabolism, suggesting that TOR is associated with coordination of several primary and secondary metabolic activities during growth and development of Arabidopsis.
Inhibition of TOR Activity Is Associated with Altered Gene Expression
We performed global RNA sequencing (RNA-seq) analysis in BP12-2 to obtain a perspective of gene expression under conditions of TOR inhibition. Comparative transcriptomes of rapamycin-treated BP12-2 line and the wild type identified a large number of differentially expressed genes (see Supplemental Data Sets 1 and 2 online). Among these, the most prominent downregulated genes under TOR inhibition in rapamycin-treated BP12-2 line were associated with major anabolic pathways, including cell wall biogenesis, photosynthesis, and inorganic nutrient transporters (see Supplemental Data Sets 2 and 3 online). By contrast, a large number of genes associated with catabolic pathways involving carbohydrates and proteins were upregulated in rapamycin-treated BP12-2 plants (see Supplemental Data Sets 2 and 3 online). In the category of cell wall biogenesis, genes downregulated in rapamycin-treated BP12-2 included structural proteins extensins, expansins, Pro-rich proteins, and arabinogalactan-and Hyp-rich glycoproteins (see Supplemental Figure 4 and Supplemental Data Set 3 online). Extensins are involved in cell wall architecture, whereas expansins function to enable plant cell expansion (Martin et al., 2001; Velasquez et al., 2011; Bruex et al., 2012) . Since cell wall development governs cell size, shape, and function (Burton et al., 2010) together with the fact that genes that enable restructuring of cell wall during growth were affected in rapamycin-treated BP12 plants, we quantified these genes and confirmed the transcriptome data using real-time PCR. All of the 16 extensin genes, seven of the nine expansin genes, and Pro-and glyco-rich cell wall protein genes tested were significantly downregulated in rapamycintreated BP12-2 compared with the wild type (see Supplemental Figure 4 and Supplemental Data Set 3 online). Also, galactinol synthase 3, involved in the synthesis of raffinose family of oligosaccharides (RFOs), was significantly downregulated. This is consistent with a decreased level of galactinol and raffinose in TOR knockdown plants. Biosynthesis of RFOs is catalyzed via the formation of galactinol from myo-inositol and UDP-Gal by galactinol synthase. Sequential transfer of Gal units from galactinol to Suc leads to the formation of raffinose and higher order RFOs (Peterbauer and Richter, 2001 ). Both galactinol and raffinose are proposed to protect plant cells from oxidative damage by scavenging hydroxyl radicals when challenged by strong oxidizing agents, such as methyl viologen or chilling stress (Taji et al., 2002; Nishizawa et al., 2008) . The low level of RFOs in rapamycin-treated plants is consistent with a lowered oxidative challenge in these plants. Taken together, these transcriptome data are consistent with and complement the carbohydrate metabolite data and suggest that TOR controls cell expansion and elongation likely via regulating the expression of the cell wall structural proteins.
Inorganic nutrition transporters that are essential for anabolic processes in plants were also downregulated in rapamycintreated BP12. This is reflected by the poor growth of rapamycintreated BP12-2 plants even when grown under nonlimiting supply of inorganic nutrients in the medium. Defensin genes that are part of the stress response pathway in Arabidopsis are upregulated (see Supplemental Figure 4 and Supplemental Data Set 1 online). In parallel with these observations is downregulation of genes encoding ribulose-1,5-bis-phosphate carboxylase/oxygenase small subunit (Izumi et al., 2012) and NDP kinase in rapamycin-treated BP12-2 plants (Choi et al., 1999) , which are important for carbon fixation and the light signaling pathway, respectively, in the chloroplast (Izumi et al., 2012) . Thus, downregulation of photosynthesis, a major anabolic process in plants, can contribute to growth defects in rapamycintreated BP12-2 plants. Similarly, defects in the development of root hairs and elongation of lateral and primary roots in rapamycin-treated BP12-2 plants are consistent with the transcriptome data showing differential expression of 40 rootrelated genes in these plants (see Supplemental Data Set 3 online). Thirty-three of these were found to be significantly downregulated (see Supplemental Data Set 3 online), including MORPHOGENESIS OF ROOT HAIR6 (MRH6), which affects root hair development (Jones et al., 2006) .
Metabolite data clearly indicated increased polyamine biosynthesis in rapamycin-treated BP12-2 plants. A limiting reaction in this pathway is catalyzed by S-adenosylmethionine decarboxylase (Mehta et al., 2002) . S-adenosylmethionine decarboxylase was one of the upregulated genes featured in rapamycin-treated BP12-2 plants whose expression was also quantified and verified (see Supplemental Figure 4 online). Thus, the transcriptome and metabolite data are congruous and support the finding that inhibition of TOR activity affects metabolic processes linked to important plant growth processes.
TOR Modulates Plant Growth in a Nutrient-Dependent Manner
The above-described data bring to the fore the nutrition relatedness of the plant TOR pathway and the question arose whether, similar to the role of TOR as a nutrition sensor in yeast and animals, TOR regulation of Arabidopsis development and metabolism are influenced by nutrition. Therefore, wild-type and BP12-2 seedling growth was followed on different concentrations of MS medium (see Supplemental Table 1 online). Wildtype plants grown on nutrient poor medium (0.0013 MS) resembled the BP12-2 plant grown on 500-fold richer medium (0.53 MS) but containing rapamycin ( Figure 4A ), indicating both nutrient starvation and TOR inhibition by rapamycin produce similar phenotypes. A gradual reduction of fresh weight in wildtype plants was observed on decreasing MS concentration in the medium ( Figure 4B ). In 0.0013 MS + rapamycin medium that provides a condition of nutrient starvation and TOR inhibition, both wild-type and BP12-2 plants displayed similar growth rates ( Figures 4C and 4D ). Under these conditions, increasing the nutrient supply up to 13 MS while maintaining the rapamycin concentration permitted a ninefold growth increase in the wild type, but not in BP12-2, whose growth remained close to that observed in 0.0013 MS + rapamycin ( Figures 4C and 4D ). These results indicated that BP12-2 plants could not respond positively to increasing nutrition levels when TOR is inhibited. Under hypernutritive conditions (23 MS + rapamycin), which also represent higher osmotic potential, growth of the wild type and BP12-2 line decreased relative to 13 MS + rapamycin ( Figures  4C and 4D ). Increasing the concentrations of nitrogen and carbon (Suc) significantly increased the growth rates of wild-type seedlings, whereas the BP12-2 seedlings with rapamycin remained insensitive to this stimulation ( Figures 4E and 4F ). We note here that S6K phosphorylation was reduced to 25.18% when nutrition was limited (see Supplemental Figure 2C online), and this is similar to the reduced level of phosphorylation (24%) when TOR is inhibited by rapamycin. Thus, nutrition starvation phenocopies the suppression of TOR kinase activity. Together, these results suggest that TOR signaling senses nutritional status and may thereby control cell growth and development.
TOR Is Required for Light Energy-Dependent Plant Growth
Plants respond positively to photosynthetic growth when light intensity is increased from suboptimal levels. This was observed with wild-type plants ( Figures 5A and 5B) . By contrast, rapamycintreated BP12-2 line failed to respond to increasing light intensities ( Figure 5A ), resulting in a growth rate that was >10-fold lower than the wild-type control ( Figure 5B ). To test the effect of combined light and nutrition conditions on plant growth, fresh weight ratio between wild-type and rapamycin-treated BP12-2 plants under various light intensities and nutrient concentrations (MS media) was determined ( Figure 5C ). The largest fresh weight ratio value, indicating a significant difference between wild-type and rapamycin-treated BP12-2 plants, was observed at 100 µmol m 22 s 21 light intensity ( Figure 5C ). This ratio peaked at 0.53 MS and was significantly lower under weak light (10 µmol m 22 s 21 ) and dark conditions ( Figure 5C ). Consistent with these observations, upon light energy limitation, TOR kinase activity was significantly suppressed similar to that observed in BP12-2 plants treated with rapamycin (see Supplemental Figure 2C online).
We next determined whether the reduction of growth and biomass of TOR suppression lines is associated with ROS and NAD(P)H reduction (Apel and Hirt, 2004) . ROS signals in the root hair of wild-type plants treated with rapamycin were similar to the control plants; however, significant reduction of ROS signals was observed in rapamycin-treated BP12-2 plants compared with the control (Figure 5D ), as was also the case with NAD(P)H levels ( Figure 5E ). Interestingly, the ratios of NADH/NAD and NADPH/NADP in BP12 lines did not differ from the wild type in response to rapamycin treatment, indicating that the homeostasis of NAD(P)H/NAD(P) is maintained in BP12 lines but the relative levels of NAD(P)H were lower compared with the wild type. Glutathione reductase uses NADPH to reduce the oxidized form of glutathione (GSSG) to the reduced form (GSH). The (B) The wild-type seedlings grown on decreasing concentrations of MS showed a consistent decrease in fresh weight (FW); BP12-2 seedlings grown on 0.53 MS with rapamycin showed similar fresh weight as the wild type grown on 0.0013 MS, whereas without rapamycin treatment in BP12-2 seedling the fresh weight was similar to the wild type grown on 0.53 MS. (C) Phenotypes of 9-DAG seedlings of the wild type and BP12-2 grown on different concentrations of MS media containing rapamycin showed that increasing concentrations of MS did not increase the growth rate of BP12-2 seedlings compared with the wild type in the presence of rapamycin. At 9 DAG, clear growth differences become apparent between the wild type and BP12-2 under rapamycin treatment. (D) to (F) Growth rates (measured in fresh weight) of 9-DAG wild-type and BP12-2 seedlings grown on increasing concentrations of MS media (D) and increasing concentrations of nitrogen (E) and Suc (F) in MS with rapamycin. FW, fresh weight; RAP, rapamycin. Error bars indicate SD for triplicates. reduction of NADPH is highly consistent with the ratio of GSH/ GSSG significantly decreasing in rapamycin-treated BP12 lines compared with the wild type control observed in metabolite profile. These results suggest a mechanistic link between light energy-TOR-ROS/NAD(P)H and plant growth.
Nutrition and Energy-Dependent TOR Function Regulates Production of rRNAs
It is estimated that cells dedicate ;80% of total transcriptional activity to the synthesis of rRNAs and proteins for ribosome biogenesis (Warner, 1999) , making ribosome biogenesis a major nutrient and energy-consuming process in growing cells (Lempiäinen and Shore, 2009 ). The TOR regulation of energy and nutrient availability is known to be mediated by alterations in protein and ribosome production (Wullschleger et al., 2006) . We therefore quantified total RNA production of wild-type and BP12-2 plants with and without rapamycin. Total RNA was significantly reduced in rapamycin-treated BP12-2 plants ( Figure 6A and inset), as also observed under light-limiting conditions ( Figure 6B and inset), nutrition starvation ( Figure 6C and inset), and carbon (Suc) or nitrogen limitation ( Figure 6D and inset). Under nutrient limitation (0.0013 MS) or when kept in the dark, no further reduction in total RNA was found in rapamycin-treated BP12-2 plants ( Figure 6E and inset). Thus, TOR requires both light and nutrition signals to regulate total RNA expression in Arabidopsis. Previously, TOR modulation of rRNA expression has been shown (Ren et al., 2011) . We quantified rRNA content in BP12-2 plants using a GFP reporter construct (45S rRNA promoter fused with GFP; Pr-RNA:GFP) previously described (Ren et al., 2011) . The GFP transcripts quantified by real time-PCR (see Supplemental Table 4 online) essentially mirrored the trends The 11-DAG wild type showed increased growth rates on 0.53 MS with rapamycin at increasing light intensities, whereas BP12-2 seedlings failed to respond to these favorable conditions. FW, fresh weight. (C) Fresh weight ratios of wild-type/BP12-2 seedlings peaked under strong light conditions and remained neutral under weak light and dark conditions when grown under different light conditions (100 µmol m 22 s 21 , 30 µmol m 22 s 21 , dark) and at various MS concentrations (0.01, 0.1, 0.5, 1.0, and 2.03) with rapamycin. Fresh weight ratio quantified the difference in response of wild-type and BP12-2 seedlings on the combined effect of light intensity and nutrition levels. (D) ROS levels as detected by H 2 DCFDA fluorescence in the root hairs of 11-DAG wild-type and BP12-2 plants grown in the presence and absence of rapamycin. Weak fluorescence signal in rapamycin-treated BP12-2 plants indicate reduced ROS levels in BP12-2 compared with the wild type. (E) NADH and NADPH levels were reduced in 11-DAG BP12-2 seedlings compared with the wild type in the presence of rapamycin. Error bars indicate SD for triplicates.
observed for the total RNA levels in the wild type and BP12-2 with analogous treatments (Figure 6 ).
TOR Suppression Significantly Extends Life Span Irrespective of Negative Effect on Biomass in Arabidopsis
In order to delineate effects of TOR suppression on growth of Arabidopsis, we examined the kinetics of phase change, flowering time, chlorophyll content, cell death rate, and the senescence-associated gene (SAG) expression in BP12-2 lines in 0.53 MS + rapamycin medium at 100 µmol m 22 s 21 fluence (Figure 7) . The BP12-2 plants characteristically had smaller rosette leaves, slower phase change, delayed flowering, and shorter roots compared with the wild type (Figures 7A to 7C ; see Supplemental Table 5 online) . By 70 DAG, the wild-type plants had senesced, whereas the BP12-2 rosettes were still green and their roots had lengthened, indicating sustained growth and longer life span ( Figure 7D ; see Supplemental Table 5 online) . Rapamycin application to BP12-2 plants even at an advanced growth stage effectively delayed their flowering time and further aging (see Supplemental Figure 5 online).
The delayed senescence in rapamycin-treated BP12-2 plants prompted us to further examine aging in the first rosette leaf pair in Arabidopsis using known assays and markers: chlorophyll Relative total RNA levels in BP12-2 and wild-type (WT) seedlings grown under different nutrient and light with or without rapamycin (RAP). RNA denatured gels are shown as insets in all panels representing RNA from samples shown in the histogram from left to right. Total RNA was isolated from the same amount (0.9 g) of seedling tissues. MS = 0.53 MS; error bars indicate SD for triplicates. (A) Decreased RNA levels in BP12-2 treated with rapamycin for 24 h compared with the wild type. (B) Decreased RNA levels in both the wild type and BP12-2 under both dark and nutrition starvation (0.0013 MS) conditions. (C) Decreased RNA levels in the wild type and BP12-2 under nutrition starvation, which is similar to that observed in rapamycin-treated BP12-2 seedlings. (D) Decreased RNA levels in the wild type and BP12-2 under carbon or nitrogen starvation. -N, without nitrogen (see Supplemental Table 2 online); -C, without Suc (see Supplemental Table 3 online) . (E) RNA levels are not further reduced in rapamycin-treated BP12-2 seedlings grown under dark or nutrition starvation conditions. content, cell death rate, and SAG12 expression levels (Noh and Amasino, 1999; Buchanan-Wollaston et al., 2005; Schippers et al., 2008) . At 32 DAG, total chlorophyll content in the leaves had only reduced by 11% in BP12-2 line in contrast with 83% in the wild type ( Figure 7E ). Cell death (measured by Evans blue staining; Guo and Crawford, 2005) was only 19% in BP12-2 compared with 94% in the wild type ( Figure 7F ). The flowering time of BP12-2 plants was delayed by 13 d compared with the wild type ( Figure 7G ). Senescence rate was also measured by quantifying SAG12 marker expression in the first leaf pair of the rosette treated with rapamycin. It should be noted that only SAG12 was used because both SAG12 and SAG13 had shown similar trends in this study. SAG12 expression in the wild type was clearly higher, and in comparison it was initiated 4 d later in the BP12-2 line but continued to gradually increase to the wildtype levels by day 44 ( Figure 7H ). Rapamycin treatment of BP12-2 consistently delayed the emergence of hypocotyl, establishment of rosette leaves, bolting, opening of the first flower, and whole-plant senescence relative to that in the wild type. Consequently, BP12-2 plants lived 17 d longer than the wild type (see Supplemental Table 5 online).
Does TOR Signaling Recruit RPS6 to Regulate Growth and Life Span of Arabidopsis?
A previous study suggested involvement of RPS6 in regulating growth processes in Arabidopsis (Creff et al., 2010) . We further pursued this observation and found that rps6 mutant lines show growth phenotypes similar to rapamycin-treated BP12-2 plants. Independent T-DNA knockout lines representing loss of function of two RPS6 homologs, rps6a and rps6b (see Supplemental Figures 6A and 6B online and Supplemental Methods 1 online), had smaller leaves, slower root growth rate, delayed phase change, delayed flowering, and longer life span in comparison to the wild type (Figures 8A and 8B ; see Supplemental Tables 5 and  6 online). Our attempts to construct double mutants of rps6a and rps6b were not successful due to lethality in the double homozygous seeds (Supplemental Methods 1 online). Interestingly, all the 54 F1 generation plants (rps6a/+ rps6b/+) confirmed by PCRbased genotyping, had the same phenotype as the rps6a or rps6b single mutants ( Figure 8C ). This further confirmed that heterozygosity of the two RPS6 genes results in dosage effect or haploinsufficiency as also previously noted (Creff et al., 2010) .
Because stronger developmental defects were observed in our studies with rps6b compared with the rps6a, rps6b plants were used for additional experiments. The smaller leaves of rps6b mutants had fewer secondary veins and the epidermal pavement cells were two-thirds the size of comparable cells in the wild type ( Figure 8D ), while the TAC zone in rps6b mutant roots was much smaller than the wild type ( Figure 8E ), similar to observations shown above in rapamycin-treated BP12-2 RAM. Complementation tests confirmed the respective mutant alleles of RPS6A and RPS6B genes ( Figure 8F ; see Supplemental Methods online). Furthermore, growth rates of rps6a and rps6b single mutants in different nutrition conditions and two light intensities were examined (see Supplemental Figure 7A online). In normal to rich nutrition medium or high light conditions, the growth rate of the mutant seedlings was slower than that of the wild type but slightly better than wild-type controls under poor nutrition or low light conditions (see Supplemental Figures 7B and 7C online). The observations of slow growth of rps6 single mutants and the lethality of the rps6a-rps6b double mutants are reminiscent of rapamycin-treated BP12-2 plants and the tor mutants, respectively (Menand et al., 2002; Ren et al., 2011) . Thus, both TOR and RPS6 are limiting factors for normal plant growth.
These findings prompted us to test if RPS6 functions as a downstream mediator (component) of TOR signaling as seem to be the case in yeast and animals. We therefore tested genetic interactions between TOR and RPS6. TOR was suppressed in the rps6 mutant by crossing BP12-2 line with T3 generation homozygous lines of rps6 carrying P35S:FKBP12. In both the rps6a and rps6b mutants carrying P35S:FKBP12, rapamycin treatment did not significantly decrease the growth rate to the levels observed in the rapamycin-treated BP12-2 line ( Figures  9A and 9B ). This indicated that TOR inhibition phenotype to manifest fully requires functional and homozygous copies of both RPS6A and RPS6B. However, the chlorophyll content ( Figure 9C ), cell death rate ( Figure 9D ), flowering time ( Figure  9E) , and SAG12 expression level ( Figure 9F ) in the rapamycintreated rps6b carrying P35S:FKBP12 followed the trend observed in rapamycin-treated BP12-2 plants and rps6b single mutants. The values were consistently intermediate between those observed in rps6b and BP12-2 lines. Rapamycin treatment produced significant increase in the life span of the rps6b mutants ( Figure 9 ; see Supplemental Table 6 online) but not to the same extent as seen in the rapamycin-treated BP12-2 line (Figure 9 ). These observations suggest that both RPS6A and RPS6B are required for TOR suppression-dependent increase in life span observed in BP12-2 plants.
Overexpression of TOR and RPS6 Leads to Accelerated Phase Change, Earlier Ripening, and Shorter Life Span
Since TOR-inhibited plants and rps6 mutants displayed delayed phase change and late flowering, we used P35S:TOR transgenic plants (Ren et al., 2011) and RPS6A and RPS6B overexpression lines (P35S:RPS6A and P35S:RPS6B) generated in this study (see Supplemental Figure 8 online; Figures 10A and 10C ) to obtain additional insights into the TOR-RPS6 connection. The TOR overexpression line (TOR-OE1) flowers and senesces earlier compared with the wild type ( Figure 10A ; see Supplemental Table 6 online). Although the first five leaves of the TOR-OE1 rosette retain a shape similar to the wild type, the latter formed more rounded leaves with short petioles ( Figure 10A ). TOR-OE1 siliques ripened earlier than the wild type ( Figure 10B ; see Supplemental Table 6 online). Both the P35S:RPS6A (RPS6A-OE1) and P35S:RPS6B (RPS6B-OE1) lines showed the following phenotypes: early flowering (see Supplemental Table 6 online), early onset of senescence in rosette leaves and siliques ( Figures  10C and 10D ; see Supplemental Table 6 online), and shorter petioles and bent siliques ( Figures 10C and 10D) . In this regard, these plants resemble the TOR kinase domain overexpression lines (Ren et al., 2011) .
The results of reduced life span in overexpressors of TOR and RPS6 (see Supplemental Table 6 online) together with the 4862 The Plant Cell (A) Slower growth with reduced leaf size and delayed flowering time in rps6a (panels 1 and 2) and rps6b (panels 3 and 4) mutants compared with the wild type (WT). rps6b mutant showed stronger phenotypes compared with rps6a.
(B) Delayed flowering of rps6a and rps6b seedlings compared with the wild type was also observed when grown on 0.53 MS medium.
(C) F1 heterozygous seedlings of rps6a/+/rps6b/+ double mutant display rps6a or rps6b single mutant phenotypes.
(D) Cleared rps6b mature leaves display defective vascular patterning as shown by reduction in the number of secondary branching veins compared with the wild type (left); scanning electron microscopy images of leaf abaxial surface showed that epidermal pavement cells are ;1.5 times smaller in rps6b mutant compared with the wild type (right).
(E) Nomarski images of cleared rps6b roots show reduced TAC zone compared with the wild type; the meristem/root cap region is bracketed in orange, and the TAC zone is bracketed in yellow.
(F) Complementation assays of rps6a and rps6b mutants: (1) PRPS6A:RPS6A genomic DNA rescued the rps6a to normal growth. (2) rps6b is completely restored by RPS6B genomic DNA. (3) and (4) rps6a and rps6b can be recovered by RPS6B and RPS6A, respectively, indicating functional equivalency of RPS6A and RPS6B in Arabidopsis.
finding that the rps6b mutation mitigates early flowering and senescence phenotypes of TOR-OE1 ( Figure 10F ) in the rps6b/ TOR-OE1 plants ( Figure 10F ) suggest that the TOR-mediated life span phenotypes require RPS6 function. We also verified the ability of rapamycin to specifically inhibit TOR using the TOR-OE1xBP12-2 line. T3 generation TOR-OE1xBP12-2 plants showed early senescence and short life span as observed in TOR-OE1 in the absence of rapamycin, but these phenotypes were suppressed in the presence of rapamycin ( Figure 10G ; see Supplemental Table 5 online) . Notably, the TOR overexpression phenotypes were suppressed by rapamycin only in lines with the yeast FKBP12 background, further confirming that rapamycin specifically inhibits TOR activity. Next, we used TOR-OE1, RPS6A-OE1, and RPS6B-OE1 lines that have high expression of the respective transgenes (see Supplemental Table 7 online) to determine the effect of TOR and RPS6 on life span in Arabidopsis. Both in the soil and on MS media, the rosette leaves of all these transgenic lines showed an early onset of senescence (see Supplemental Figures 9A to 9C online) with rapid decrease in chlorophyll content (at 24 DAG,
, and RPS6B-OE1 [25%] in contrast with 6% in the wild type) (see Supplemental Figure 9D online) and faster cell death rate (see Supplemental Figure 9E online). Thus, TOR and RPS6 overexpression contribute to accelerated senescence and flowering time. These observations are consistent with SAG12 and SAG13 expression, detected in the wild type at or after 24 DAG but expressed as early as 16 DAG in TOR and RPS6 overexpression lines (see Supplemental Figures 9F and 9G online) . At 36 DAG, SAG13 expression in TOR and RPS6 overexpression lines was ;200 and ;1000-fold higher, respectively, relative to the wild type (see Supplemental Figure 9G online). Collectively, these results demonstrated that the high TOR and RPS6 expression levels (see Supplemental  Table 7 online) confer faster growth cycle and decreased life span in Arabidopsis.
RPS6 Expression and Localization Overlaps with TOR
We hypothesized that if TOR and RPS6 products have overlapping functions, they should colocalize to same cellular (A) and (B) Rapamycin-treated rps6a/BP12-2 and rps6b/BP12-2 plants display partially suppressed slower growth and delayed bolting phenotypes observed in rapamycin-treated BP12-2 at 35 DAG (A) and 45 DAG (B). (C) to (F) The partial suppression of slower growth and delayed bolting phenotypes observed in rapamycin-treated rps6a/BP12-2 and rps6b/BP12-2 plants compared with rapamycin-treated BP12-2 were further defined by suppression of delayed chlorophyll degradation (C), cell death rate (D), flowering time (E), and SAG12 expression (F). For SAG12 expression, wild-type (WT) values were set as 1. Error bars indicate SD for triplicates. location(s). Therefore, subcellular localization of RPS6A and RPS6B was determined by transient expression of P35S:RPS6A-GFP and P35S:RPS6B-GFP fusion constructs in onion epidermal cells. The GFP signal of RPS6A and RPS6B was found localized both in the nucleus and cytoplasm ( Figures 10I and 10J) , which is similar to previously observed localization of TOR (Ren et al., 2011) . In addition to their colocalization, we also determined that they share overlapping expression patterns. Both PRPS6A: GUS (for b-glucuronidase) and PRPS6B:GUS were found to be ubiquitously expressed in the seedling and inflorescence tissues and closely resembled the expression pattern observed with PTOR:GUS ( Figure 10H ). These overlapping expression and subcellular localization patterns for TOR, RPS6A, and RPS6B along with similar phenotypes in their loss-and gainof-function lines support our contention that these genes perform coordinated functions in the TOR signaling pathway in Arabidopsis.
TOR and RPS6 Modulate Protein Synthesis
Protein synthesis is integral to active growth of organisms (Tavernarakis, 2008) . We surmised that TOR-and RPS6-dependent Overexpression of RPS6A (RPS6A-OE1) and RPS6B (RPS6B-OE1) also produced rounded and short petiole leaves that display early senescence (C) and early ripening siliques ([D] and [E] ). The early senescence phenotype of TOR-OE1 is partially suppressed by rps6b mutant (F) and rapamycintreated BP12-2 (G). Seedlings and inflorescences of PTOR:GUS, PRPS6A:GUS, and PRPS6B:GUS lines showed similar patterns of GUS reporter expression (H). WT, the wild type. (I) and (J) Nuclear and cytoplasmic localization of transiently expressed RPS6A-GFP (I) and RPS6B-GFP (J) proteins in onion epidermal cells; left, middle, and right panels show bright-field, GFP, and 49,6-diamidino-2-phenylindole, respectively. pathways in Arabidopsis would also be associated with active protein synthesis. Changes in the rate of protein synthesis was followed by quantifying GUS activity using 4-methylumbelliferylbeta-D-glucuronide fluorometric enzymatic assays in the leaves of the wild type and TOR-OE1, RPS6A-OE1, and RPS6B-OE1, BP12-2, rps6a, and rps6b transgenic Arabidopsis lines carrying a single copy of the P35S:GUS construct. The GUS activity in the leaves of TOR and RPS6 overexpression lines was four and two times, respectively, that of the wild-type leaves (see Supplemental Figure 10 online), and a significant reduction was seen in rps6a (27%) and rps6b (31%) leaves (see Supplemental Figure 9 online). In the presence of rapamycin, GUS activity was reduced by 61% in BP12-2 leaves compared with the wild type (see Supplemental Figure 10 online). Thus, we inferred from this reporter study that protein synthesis was significantly upregulated in lines overexpressing TOR or RPS6 and downregulated in TOR or RPS6 suppressors. Taken together, these data show that the role(s) of TOR and RPS6 in growth rate and life span in Arabidopsis are linked with rRNA, total RNA production, and protein synthesis.
DISCUSSION
Organismal life span is a fundamental and intriguing aspect of biology. New insights into basic regulators controlling growth and life span in yeast and animals have brought to the fore the TOR signaling pathway as a central component of this network (Fontana et al., 2010; Zoncu et al., 2011) . As autotrophic organisms with a fundamentally different growth, development, and differentiation regime, plants present a paradigm of their own in this regard. In this respect, our knowledge of the involvement of TOR in these processes is rudimentary. Major advances in the current understanding of the functions of TOR signaling in yeast and animal systems were made possible by the development of several key molecular, biochemical, and genetic tools, including rapamycin-dependent conditional TOR repression systems (Harrison et al., 2009; Bjedov et al., 2010; Loewith and Hall, 2011) . By contrast, such tools are either lacking or limiting for addressing TOR signaling in plants. Even though conditional rapamycin-sensitive systems using yeast and human FKBP12 transgenes have been reported, they were not explored extensively to dissect the TOR functions in plant systems, especially involving mid to late phases of development Leiber et al., 2010) . In this study, we took advantage of the relevant previous findings and established rapamycin-sensitive BP12 lines in Arabidopsis carrying the yeast FKBP12. Our results show that rapamycin treatment caused growth inhibition in all independent BP12 transgenic lines. This effect was specific such that this treatment caused no detectable phenotypic differences in the growth or phenology of wildtype plants (treated or untreated) and untreated BP12 plants. These results are consistent with earlier observations of wildtype Arabidopsis growth and development not being sensitive to rapamycin (Xu et al., 1998; Menand et al., 2002; Mahfouz et al., 2006; Sormani et al., 2007; Leiber et al., 2010) . BP12-2 is a single-copy line that represented the rapamycin-sensitive lines we had generated. With a derivative of this line carrying human S6K, we showed that rapamycin reduced T389-S6K phosphorylation by TOR, thus establishing that TOR kinase is inhibited by rapamycin in BP12-2. In contrast with these observations and those mentioned above, a recent report has indicated that rapamycin affects TOR activity in wild-type Arabidopsis (Xiong and Sheen, 2012) . In that study, the concentration of rapamycin that inhibited seedling growth was 10 µM (equivalent to 9.14 mg/mL), but no phenotypic changes were apparent at 1 and 5 µM rapamycin. Also, they used Glc in the liquid medium where the effective rapamycin dose experienced by the seedlings is likely higher, but studies including ours and previous reports employed solid medium and Suc. The presence of Glc in the medium may have also contributed to the altered responses in their study (Xiong and Sheen, 2012) . In numerous trials in experiments, we have not noticed any phenotypic change in wild-type Arabidopsis seedlings even at 21.8 mM (20 mg/mL) rapamycin. Our results clearly show that transgenic Arabidopsis lines expressing yeast FKBP12 are conditionally sensitive to rapamycin and that rapamycin specifically targets TOR protein. In our metabolite analysis, both BP12 lines displayed rapamycin-dependent response, and the TOR overexpression line in the presence of the FKBP12 transgene showed rapamycin-dependent suppression of the overexpression phenotypes indicative of both specificity and function. We demonstrated that TOR signaling is important in plant growth and longevity, particularly in the development of roots, root hairs, leaf, and shoot. We have also shown that TOR, in concert with RPS6, regulates cell size, growth, flowering time, senescence, and life span in Arabidopsis.
Inhibition of TOR Rebalances the Nutrition and Energy Homeostasis
The roots, including the root hairs, function as efficient sensing systems that rapidly signal rhizosphere concentrations of nutrients and thus monitor the fluctuations in both time and space. The elongation of roots and root hairs is essential for uptake of nutrients from the soil/medium. In this study, we showed that inhibition of TOR activity in Arabidopsis significantly suppressed primary and lateral root growth by reducing TAC production, resulting in a smaller RAM, thus also linking TOR functions to root meristem. Furthermore, the growth of root hairs was also significantly inhibited, consequently reducing the rate of nutrient uptake. Consistent with this, the global transcriptome analysis further showed that inhibition of TOR activity evokes downregulation of root hair-related genes, viz., MRH6 and LRX1. It is interesting to note that ROL5, a putative downstream component of the TOR pathway, was previously implicated in root development in Arabidopsis (Leiber et al., 2010) . Furthermore, we observed a reduced level of ROS signal in root hairs upon TOR inhibition. This is consistent with an earlier study that showed ROS accumulation in developing root hair cells was essential for their elongation (Foreman et al., 2003) . It has also been shown that ROS induction is critical for plant development (Mittler et al., 2011) . For example, mutations in genes involved in ROS generation (e.g., respiratory burst oxidase homolog [rboh] genes in Arabidopsis) compromise growth and development; plant size is affected in rbohF mutants, whereas root and root hair elongation is suppressed in rbohC (rhd2) mutants (Torres et al., 2002; Foreman et al., 2003) . Placing these root phenotypes in the context of extended life span in TOR knockdown plants suggests that TOR likely acts as a key nutrition sensor in plants by regulating the development of the root system and its associated functions.
Leaves are the major photosynthetic organs that supply carbon for plant growth. Inhibition of TOR activity significantly reduced leaf size (Figures 2 and 7 ) and failed to increase growth rate and biomass in response to increasing light intensities ( Figure 5 ). In addition, TOR inhibition caused downregulation of biochemical and genetic markers of carbon fixation: ribulose as a precursor of ribulose-1,5-bisphosphate for the Calvin cycle; the small subunit of ribulose-1,5-bis-phosphate carboxylase/ oxygenase (which catalyzes carbon fixation), and NAD(P)H (the reducing power) (Figure 5 ; see Supplemental Figures 3A and 4 online). These results suggest that TOR functions mediate nutrient uptake and light energy utilization in Arabidopsis and likely in other plants.
TOR Inhibition Is Associated with Restructured
Metabolism, Transcriptome, and Life Span TOR functions as a major growth regulator by integrating the nutrient and energy requirements to promote anabolism while inhibiting the catabolism in yeast and animals (Laplante and Sabatini, 2012) . In plants, previous studies showed that suppression of TOR either by ethanol-induced TOR RNA interference (RNAi) or by mutation of LST8, a partner of TOR, causes growth and developmental arrest and evokes restructuring of metabolite/transcript profiles, including accumulation of soluble sugars and amino acids, downregulated cell wall-associated gene expression, hypersensitivity to high sugar concentration, and decreased polysome/ribosome content (Deprost et al., 2007; Moreau et al., 2012) . Consistent with this, in this study, rapamycin-treated BP12 plants resembled the wild-type plants undergoing nutrient starvation and light energy limitation, and this was linked to a threefold reduction in TOR kinase activity. This translated into a reduction in growth, cell size, fresh weight, rRNA, and protein to ;25% that of control, respectively. Importantly, when TOR is inhibited by rapamycin, BP12 plants failed to respond to the increasing levels of nutrient and light energy, implicating nutrition and energy sensing functions of TOR for plant normal growth and development. To adapt to these conditions of nutrient and energy limitation, BP12 plants likely restructured their metabolic balance by upregulating the glycolysis, amino acid, and TCA pathway, resulting in the accumulation of their intermediates, which likely contribute as an alternate nutrient and energy source for survival. TOR negatively regulates autophagy and inhibition of TOR likely results in selective autophagy, which enables recycling of cellular nutrients (Liu and Bassham, 2012) . Consistent with this, rapamycin-treated BP12 plants displayed accumulation of the intermediates in glycolysis, amino acid, and TCA pathway. There was also a lower abundance of dipeptides paralleling the accumulation of amino acids in rapamycin-treated BP12, implicating TOR inhibition in suppression of anabolic processes in Arabidopsis.
TOR inhibition by rapamycin treatment in BP12 plants highly mimics the metabolite and transcriptome profiles observed in TOR RNAi and lst8 mutant plants (Deprost et al., 2007; Moreau et al., 2012) . However, TOR RNAi caused etiolation and lethality, whereas rapamycin inhibition in BP12 plants did not abolish the essential functions but slowed plant growth and development. The lethal phenotypes of the inducible TOR RNAi lines is likely due to the inhibition of both TORC1 and TORC2 complexes (Deprost et al., 2007) , whereas the TOR repression observed in BP12 is likely mediated through TORC1. These observations indicate the tight connectivity among TOR kinase activity, nutrient/ energy status, metabolism, and growth in plants. Taken together, these data suggest that TOR plays several critical roles to control nutrient and light energy-dependent growth by modulating metabolic processes.
ROS and NADPH are key metabolites involved in various important cellular functions. In yeast and animals, mitochondria are the major source of ROS and NAD(P)H. Therefore, increased TCA flux would lead to an increase in ROS and NAD(P)H. In plants, because of photosynthesis, chloroplasts are a major source of ROS and NAD(P)H (Dietz and Pfannschmidt, 2011) . In TOR knockdown plants, severely retarded leaf development likely resulted in lower photosynthetic efficiency, which may account for the reduced levels of total ROS and NAD(P)H levels compared with the wild type ( Figures 5D and 5E ). Glutathione reductase uses NADPH to reduce the oxidized form of glutathione (GSSG) to the reduced form (GSH). Although the glutathione content is increased in the metabolite profile of rapamycin-treated BP12-2 plants, the ratio of GSH/GSSG was significantly decreased in rapamycin-treated BP12 lines compared with the wild-type control, indicating that BP12 plants actively dampen ROS levels at the cellular level as part of the restructured metabolism for sustainable growth and development in the presence of rapamycin. Decreased levels of NADPH without a change in the ascorbate levels or ascorbate/dehydroascorbate ratio may also explain the elevated levels of total glutathione but a lower GSH/GSSG ratio in rapamycin-treated plants (see Supplemental Figure 11 online). One of the specific functions of glutathione in plants is to maintain the levels of ascorbic acid by the nonenzymatic reduction of dehydroascorbate. Ascorbic acid acts as an electron donor in the reduction and detoxification of hydrogen peroxide and dehydroascorbate formed in the process must be rereduced in order to prevent a drop in the total ascorbate pool (Noctor et al., 1998 ). An accumulation of oxidized glutathione (GSSG) levels is known to trigger Glu-Cys ligase, the rate-limiting enzyme in glutathione biosynthesis (Hicks et al., 2007) , which is consistent with the elevated levels of total glutathione in rapamycin-treated plants that we have observed (see Supplemental Figure 11 online). Recently, overexpression of a NAC transcription factor, JUNGBRUNNEN1 (fountain of youth), of Arabidopsis was shown to reduce ROS levels, delay senescence, and increase longevity (Wu et al., 2012) , which agrees with our observations of lower ROS levels and increased longevity in TOR-suppressed BP12 lines.
The polyamine pathway was upregulated, diamine putrescine and its precursors, together with its rate-limiting gene, Sadenosylmethionine decarboxylase (Mehta et al., 2002) , featuring characteristically with TOR inhibition. Interestingly, the noted redirection of carbon (C) and nitrogen (N) metabolism in TORinhibited plants may well be connected to polyamines since such a connection of polyamines with anabolic processes and C:N signaling has been previously reported (Mattoo et al., 2006; Handa and Mattoo, 2010) . C:N metabolism is intimately connected with plant growth and development (Nunes-Nesi et al., 2010) . A polyamine connection with increased longevity has also been indicated in studies with yeast and animal models (Eisenberg et al., 2009 ) and delayed ripening and extended vegetative phase of growth in transgenic tomato (Solanum lycopersicum) plants expressing yeast spermidine synthase (Nambeesan et al., 2010) . Thus, several other cellular signals may be in tune with TOR to integrate the nutrient and energy requirements with anabolism in plants.
Cell wall remodeling is a limiting factor for growth. Cell growth depends on cell elongation and expansion that involves cell wall loosening and addition of cellulosic microfibrils (Martin et al., 2001) . The expansins and extensins are the major structural proteins of cell wall and play an important role in restructuring cell growth. The results from our global transcriptome analysis showed that a significant downregulation of the extensins and expansins occurred in TOR suppression plants, indicating that TOR is a crucial regulator of cell wall biogenesis, consistent with a recent study (Moreau et al., 2012) .
Plants attempt to complete their lifecycle as an avoidance mechanism against environmental stresses, such as drought and salinity, and the life span is therefore shortened. Although certain gene expression signatures resembling stress responses were seen in TOR suppressed lines, these responses did not result in hastened lifecycle. The extended life span suggests that the TOR suppression resembles the calorie restriction-mediated programs observed in yeast and animal model systems (Fontana et al., 2010) . The 17-d extension of life span in BP12-2 recorded in our study resembles the 25% extension of life span in rapamycin-fed mouse (Harrison et al., 2009) . These parallels suggest conservation of several key functions of TOR, including control of life span in plants as observed in other diverse eukaryotes.
RPS6 Is an Important Mediator of TOR Signaling in Arabidopsis
In Arabidopsis, the sequential phosphorylation cascade of TOR, S6K, and RPS6 is suggested to be conserved (Mahfouz et al., 2006) . Notably, when Arabidopsis S6K is expressed in animal cells, it can substitute the animal S6K to phosphorylate RPS6 protein (Turck et al., 1998 ). An S6K double mutant displays an embryo lethal phenotype similar to tor knockout mutant lines in Arabidopsis (Henriques et al., 2010) . Notwithstanding this conservation, TOR-independent functions of S6K and RPS6 in plants have also been observed (Mahfouz et al., 2006; Creff et al., 2010; Henriques et al., 2010) . Overexpression of S6K, unlike that of TOR or RPS6, does not advance flowering or senescence in Arabidopsis (Mahfouz et al., 2006; Henriques et al., 2010) . This suggests that other upstream kinases, like pyruvate dehydrogenase kinase and signaling factors of hormonal pathways, may be involved in the phosphorylation of S6K (Turck et al., 2004; Mahfouz et al., 2006) . The observation that rps6 mutations retard growth to a lesser extent than low light or nutrition (in the wild-type background) and in combination with the more severe growth retardation by TOR inhibition (in BP12-2) indicates that RPS6 also has some functions that are independent of TOR signaling in Arabidopsis. Indeed, another study has shown that RPS6 as the key phosphoprotein of the 40S ribosome is targeted by various upstream kinases in (A) High TOR-RPS6 expression levels confer early flowering and early onset of leaf senescence indicative of shorter life span, whereas low TOR-RPS6 expression leads to slower growth as a result of restructured metabolism, late flowering, and delayed onset of leaf senescence, which are indicative of longer life span during postembryonic development. Loss of TOR and RPS6 functions leads to early embryo lethality. (B) Components of the TOR signaling pathway regulate growth and life span likely through ribosome biogenesis and protein translation that influences the overall growth rate and life span. Suppression of TOR signaling influences the overall metabolic rate via increased catabolism and decreased anabolism, which results in delayed growth rate and extended life span. Furthermore, light energy and nutrition status have a major influence on the TOR pathway, and characterization of other players in this process will aid to advance our understanding of life span regulation in Arabidopsis and other important plant species.
addition to TOR and S6K kinases to regulate many biological processes in response to various growth and stress signals (Turck et al., 2004) . Interestingly, mutations in many ribosome protein genes of plants also display growth-related phenotypes similar to RPS6 (Byrne, 2009 ), indicating that they perform similar essential functions as key components of translation machinery. It is possible that some or majority of these ribosomal proteins are likely regulated at least in part by TOR.
Evidence presented here favors overlapping functions of TOR with RPS6. Unlike TOR, which is a single-copy gene in the Arabidopsis genome, RPS6 is present as two closely related genes (RPS6A and RPS6B). As with TOR, RPS6 function is essential for embryo viability. Interestingly, our results show that loss of function mutation in any one of the two RPS6 genes results in slower growth and developmental phenotypes, such as smaller leaves, shorter roots, and smaller RAM, similar to that observed in rapamycin-treated BP12-2 plants. Furthermore, the functions of RPS6 are regulated in a dose-dependent manner as shown by the heterozygous double mutants of rps6a and rps6b that resemble the single mutant and homozygous double mutants that are lethal like the tor mutants. Consistent with the loss-of-function studies, overexpression of RPS6A or RPS6B produced phenotypes that resembled TOR overexpression lines in that they showed an opposite effect to that seen with inhibition of TOR. We therefore propose that RPS6 is a downstream component of the TOR signaling pathway in Arabidopsis. The advancement of phase change during the vegetative development, early flowering, and onset of leaf senescence in the RPS6 overexpression lines also show that RPS6 is a downstream component in the TOR pathway in plants. With reference to the senescence of leaves, SAG12 and SAG13 marker gene expression (Quirino et al., 2000) also correlated well with chlorophyll loss and greater cell death when TOR or RPS6 was overexpressed (see Supplemental Figure 9 online). Consistent with these observations, the old5 mutant of Arabidopsis that has a shorter life span than the wild type undergoes accelerated aging as shown by early senescing leaves and early SAG expression (Schippers et al., 2008) . Furthermore, loss of chlorophyll in TOR or RPS6 overexpression lines likely involves internal reallocation of storage reserves from the old leaves to the developing flowers and fruits to accelerate the phase change and to shorten the life span as previously implied for loss of chlorophyll (Lim et al., 2007) .
In summary, our results show that growth rate, phase change, and life span of Arabidopsis are regulated through modulation of TOR-RPS6-dependent pathways that link nutrition and light signals. Based on our studies, we present a working model highlighting the role of TOR pathway in plants (Figure 11 ). In this model, loss of TOR or RPS6 activity results in lethality since both are critical for cell survival (Menand et al., 2002; Creff et al., 2010; Ren et al., 2011) . However, by modulating the levels of TOR or RPS6 expression, the growth, flowering time, and senescence can be altered to produce a longer or shorter life span in Arabidopsis. Also, ribosome biogenesis and protein synthesis are important players in this regard as observed in other eukaryotes (Ruvinsky and Meyuhas, 2006) . As TOR couples light and nutritional signals with ribosome biogenesis, the processes associated with specific cellular metabolism are also implicated in the regulation of life span in Arabidopsis. Plants have a remarkable ability to survive and grow under extreme conditions, such as very low light and nutrition deprivation, and display a remarkable plasticity in growth and life span. It is conceivable that TOR and its associated signaling components contribute to making plants resilient under unfavorable environments. Future research in plant TOR signaling should help to advance the critical understanding and provide new insights in this important field.
METHODS
Arabidopsis thaliana Growth and Transformation
In this study, the wild-type Arabidopsis Columbia (Columbia-0) ecotype was used. Arabidopsis seedlings and plants were grown in growth chambers with 22°C and 16-h/8-h light/dark cycle settings unless indicated otherwise. Transgenic plants were generated by the floral dipping method (Zhang et al., 2006) . Arabidopsis growth, transformation, and screening of primary transformants were performed according to the published protocols (Zhang et al., 2006) .
Isolation and Characterization of T-DNA Insertion Lines
The mutants rps6a (SALK_012147) and rps6b (SALK_061539) in Columbia background were obtained from the ABRC. Detailed information describing mutant lines is listed in Supplemental Table 8 online. The knockout lines were identified and confirmed by PCR using primers designed using the T-DNA Primer Design website, http://signal.salk.edu/ tdnaprimers.2.html. The details of these primers are listed in Supplemental Table 9 online.
Growth Rate Measurement
To measure the rate of plant growth, sterilized seeds were planted on the nutrient-solidified agar plates. Plates were sealed with Parafilm and held vertically in the growth chamber under the indicated light and temperature conditions. The seedling samples were harvested, and the fresh weight was examined 11 DAG. For rapamycin treatments, exposure of BP12 plants to different concentrations (0.5, 1, 5, 10, and 20 µg/mL) of rapamycin showed that 10 mg/mL rapamycin was the optimal concentration to inhibit TOR as also documented in the previous study . In nutrition limitation or light limitation conditions, the wild-type control and BP12-2 transgenic plants or rps6 mutants were germinated on the same plate containing 10 µg/mL rapamycin (Bioshop Canada) or the same nitrogen/carbon concentration unless indicated otherwise. Rapamycin was dissolved in DMSO (Fisher ChemAlert). It was noted that MS plates containing 1 µL/mL DMSO had no effects on the growth of wildtype, BP12-1, BP12-2, BP12-4, and BP12-5 plants compared with MS plates lacking DMSO (see Supplemental Figure 1B online). Therefore, MS/ DMSO plates are referred as MS plates in all the rapamycin treatment assays. Each fresh weight data point represents the average of three independent experiments.
Generation of Overexpression Constructs
The full-length coding sequence of RPS6A (750 bp) and RPS6B (753 bp) was amplified by RT-PCR using the Advantage 2 Polymerase Mix kit (Clontech) following the manufacturer's instructions. RT-PCR primer pairs for amplification of the full-length genes from Arabidopsis were designed based on the cDNA sequence (http://www.Arabidopsis.org). These primers introduced a NotI site at the 59 end of the respective forward primer and an XmalI site in the 39 end of reverse primer. The PCR products, with the 59 NotI site and 39 XmalI site, were cloned into the TA cloning vector pCR2.1-TOPO (Invitrogen). The recombinant clones were verified by DNA sequencing and cloned into p8GWN (Ren et al., 2011) to generate the Gateway system-based Entry vector (Earley et al., 2006) . Similarly, the coding sequence of full-length yeast FKBP12 (345 bp) containing NotIXmaI restriction sites was PCR amplified from yeast genomic DNA and cloned into the NotI-XmaI sites of LR reaction gateway entry vector p8GWN (Ren et al., 2011) to generate Gateway entry vector constructs. The Gateway system (Invitrogen) was employed for creating different overexpression constructs, which were developed by transferring target genes from p8GWN into the appropriate pEarleyGate vectors (pEarleyGate 201 containing HA tag; pEarleyGate 201 containing cMyc tag and pEarleyGate 103 containing GFP) through LR recombination reactions in Escherichia coli (Earley et al., 2006) to generate RPS6A-OE(P35S:HA-RPS6A), RPS6B-OE(P35S:cMyc-RPS6B), P35S:RPS6A-GFP, and P35S: RPS6B-GFP. The lines of TOR-OE (P35S:TOR) were described previously (Ren et al., 2011) . The resulting plasmids were used to transform wild-type Arabidopsis plants (Columbia-0) for developmental and phenotypic analyses or onion (Allium cepa) cells for cellular localization studies.
Generation of Promoter-GUS and Complementation Constructs
Based on our previous PrRNA:GFP construct (Ren et al., 2011) , the PrRNA was replaced by the promoters of TOR (2.7 kb), RPS6A (1.2 kb), and RPS6B (2.1 kb) through AsisI and NotI restriction sites, respectively. Furthermore, the GFP was replaced by 1.8-kb GUS marker gene containing NotI-XmaI restriction sites and PCR amplified using forward primer GUSF and reverse primer GUSR (see Supplemental Table 10 online). The constructs of PTOR:GUS, PRPS6A:GUS, and PRPS6B:GUS were transferred into destination vector pEarleyGate303 through LR recombination reactions. Based on PRPS6A:GUS and PRPS6B:GUS constructs, the GUS gene was replaced by 2632-bp genome fragment containing the RPS6A and 1406-bp genome fragment of RPS6B coding sequence to generate PRPS6A:RPS6A and PRPS6B:RPS6B complementation vectors. The corresponding primers are listed in Supplemental Table 10 online. The resulting plasmids were used to transform wild-type Arabidopsis plants (Columbia-0) for expression analysis and rps6a or rps6b mutants background for complementation studies.
GFP Transient Expression and Particle Bombardment
Particle bombardment was performed as described (Ren et al., 2011) .
Measurements of Chlorophyll Content and Cell Death Rate
The relative chlorophyll content, cell death rate, and SAG12/SAG13 expression level in the first leaf pair was measured every fourth day starting from 20 to 44 DAG. Chlorophyll was extracted from the first leaf pair and quantified (Weaver and Amasino, 2001 ). The chlorophyll content at 20 DAG was used as the reference (values set as 100%), to which the relative chlorophyll contents in experimental samples were compared. The cell death rate was determined after spectrophotometric measurement of absorbance at 600 nm (Guo and Crawford, 2005) . The cell death rate at 44 DAG was used as the reference control (values set as 100%) for the relative cell death rates shown in the figures. Each data point represents the average of three pools of the first leaf pair taken from separate plants at each sampling time.
DNA Gel Blotting and Immunoblotting
The genomic DNA samples were isolated from the leaves at 20 DAG of BP12 lines. DNA gel blotting was performed using DIG-High prime DNA labeling and detection starter kit II (Roche) following the protocol provided with the kit. Total protein was extracted from 100 mg of fresh leaf tissue obtained from 3-week-old plants with 300 mL extraction buffer (0.1 M Tris-HCl, pH 8.0, 0.01 M MgCl 2 , 18% [w/v] Suc, and 40 mM 2-mercaptoethanol). SDS (2%, w/v) was added to extraction buffer to solubilize membrane and other insoluble proteins. Protein samples were subjected to SDS-PAGE and transferred to Hybond-P polyvinylidene difluoride transfer membrane (Amersham). Membranes were blocked with 5% ECL blocking agent (dissolved with 13 TBST) and then incubated with 1:2000 diluted primary antibody (mouse anti-c-Myc). After three washings with 13 TBST, the blot was incubated with 1:5000 diluted horseradish peroxidase-conjugated goat anti-mouse IgG antibodies. Supersignal west pico chemiluminescent substrate (Thermo Scientific) was used for signal detection.
Quantitative Real-Time PCR Real-time PCR was performed as described previously using the Step One Real-Time PCR system from Applied Biosystems (Ren et al., 2011) . The primers used in this study are listed in Supplemental Table 11 online.
Biochemical Assays
For the GUS assay, the GUS activity and staining were performed as described previously (Jefferson et al., 1987; Jefferson, 1989) .
For the NAD/NADH and NADP/NADPH assay, 11-DAG wild-type and BP12-2 seedlings were collected in the presence of rapamycin, ground in liquid nitrogen, and assayed as described in the e.ENZYME LLC kit instructions. Three biological replicates were used for each assay.
For the p70-S6K [pT389] phosphorylation assay, S6K/BP12-C seedlings at 15 DAG were treated with rapamycin, dark and nutrient starvation for 3 d by transferring the seedlings from half-strength MS medium to halfstrength MS + 10 mg/mL rapamycin, half-strength MS + dark, and 0.0013 MS, respectively, along with control (half-strength MS + 1 mL/mL DMSO) were used. The ELISA assay was performed on seedling extracts made following the kit manual (p70-S6K [pT389] human ELISA kit; Invitrogen). Three biological replicates were used for each assay.
ROS Detection
The probe 29,79-dichlorofluorescin diacetate (H 2 DCFDA) (Molecular Probes/ Invitrogen) was used at 20 mM to detect ROS. The roots were treated with the H 2 DCFDA for 45 min at 4°C and washed twice in the same buffer, and then images were captured with Leica SP5 confocal microscope using 488-nm/ 522-nm excitation/emission.
Microscopy
Cellular details were observed with a Leica DMR microscope after clearing the tissues in a chloral hydrate solution (8:1:2 chloral hydrate/glycerol/ water [w/v/v]), and the images were captured using a Microfire camera (Optronics). Scanning electron microscopy was performed as described previously (Venglat et al., 2002) . Confocal images of the palisade and spongy mesophyll cells were captured with the Leica SP5 confocal microscope after staining the tissues with propidium iodide.
Metabolite Analysis
Wild-type, BP12-2, and BP12-5 seedlings (incubated in growth chambers with the following settings: 22°C, 16-h-light [7 AM to 11 PM]/ 8-h-dark cycle, and 100 µmol m 22 s 21 light intensity) at 15 DAG were treated with rapamycin for 3 d by transferring from 0.53 MS medium to 0.53 MS + 10 mg/mL rapamycin along with control (0.5 MS + 1 mL/mL DMSO). Samples collected between 1 and 2 PM were ground in liquid nitrogen and freeze dried for 6 d under vacuum. Four biological replicates for each of these samples were further processed and analyzed by Metabolon for global unbiased metabolite profiling involving a combination of three platforms: ultra-HPLC-tandem mass spectrometry optimized for basic species, ultra-HPLC/tandem mass spectrometry optimized for acidic species, and gas chromatography-mass spectrometry. Methods used were as described previously (Evans et al., 2009; Oliver et al., 2011) .
Metabolite Heat Map Generation
Wild-type, BP12-2, and BP12-5 seedlings at 15 DAG were treated with rapamycin for 3 d by transferring from 0.5 MS medium to 0.5 MS + 10 µg/mL rapamycin along with control (0.5 MS + 1 µL/mL DMSO). Four lanes in the heat map for each treatment correspond to four biological replicates. Raw data for each compound from the entire metabolic profiling data set were scaled to the median of the detected values, and null values were imputed with the minimum value detected for the compound. A log 2 transformation was then performed, which rendered the median values as zero. False color was applied as indicated in the legend scale, in both cases with color saturation at two log 2 units above or below the median, with yellow representing values higher than the median and blue representing values lower than the median. Compounds in the figure were blocked by general pathway group as indicated. Supplemental Figures 3A to 3E online list the respective compound names and their mean values for each pathway group. Rapamycin, indicated by red arrow, was at detectable levels in all treated plants, but not in any of the untreated plants, as expected.
RNA-Seq Data Analysis
Paired-end alignments were obtained through aligning short reads onto the reference Arabidopsis genome (TAIR9) using Bowtie (http://bowtie-bio. sourceforge.net/index.shtml). Approximately 70% of the reads mapped to at least one genomic location on either of the two strands. For those reads that did not align to the genome, a second-round alignment was performed in which we recursively trimmed one base at a time (up to 21-mers) at either the 59 or 39 end of the reads until we found a (perfect) match to the genome. Finally, more than 80% of the reads mapped onto the genome. Htseq-count (http://www-huber.embl.de/users/anders/HTSeq/doc/count.html) was used to count the reads from the Bowtie derived output files. Differentially expressed genes were identified using edgeR (http://www.bioconductor. org/packages/release/bioc/html/edgeR.html). The false discovery ratecorrected P value for differential expression was set to be #0.05.
For Gene Ontology (GO) analysis, GO terms were obtained from The Arabidopsis Information Resource. GO enrichment analysis was conducted as described previously (Fu et al., 2009; Paliouras et al., 2011) . Specifically, to identify differentially expressed GO terms, we considered the gene expression values for the GO analysis using parametric analysis of gene set enrichment (Kim and Volsky, 2005) .
Accession Numbers
Sequence data from this article can be found in the Arabidopsis Genome Initiative or GenBank/EMBL databases under the following accession numbers: TOR, At1g50030; yeast FKBP(12), YNL135C; Arabidopsis S6K, At3g08730; human S6K, NM_003161; RPS6A, At4g31700; and RPS6B, At5g10360. The RNA-seq data have been uploaded to the Gene Expression Omnibus under accession number GSE42968.
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